CY1112180T1 - 1-κεστοζη για θεραπεια αλλεργιας και ατοπικης δερματιτιδας - Google Patents
1-κεστοζη για θεραπεια αλλεργιας και ατοπικης δερματιτιδαςInfo
- Publication number
- CY1112180T1 CY1112180T1 CY20111100834T CY111100834T CY1112180T1 CY 1112180 T1 CY1112180 T1 CY 1112180T1 CY 20111100834 T CY20111100834 T CY 20111100834T CY 111100834 T CY111100834 T CY 111100834T CY 1112180 T1 CY1112180 T1 CY 1112180T1
- Authority
- CY
- Cyprus
- Prior art keywords
- effect
- allergy
- kestose
- production
- antibody
- Prior art date
Links
- 208000026935 allergic disease Diseases 0.000 title abstract 5
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 4
- 230000007815 allergy Effects 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 7
- VAWYEUIPHLMNNF-OESPXIITSA-N 1-kestose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 VAWYEUIPHLMNNF-OESPXIITSA-N 0.000 abstract 4
- GIUOHBJZYJAZNP-DVZCMHTBSA-N 1-kestose Natural products OC[C@@H]1O[C@](CO)(OC[C@]2(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O GIUOHBJZYJAZNP-DVZCMHTBSA-N 0.000 abstract 4
- VAWYEUIPHLMNNF-UHFFFAOYSA-N kestotriose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 VAWYEUIPHLMNNF-UHFFFAOYSA-N 0.000 abstract 4
- 241000186000 Bifidobacterium Species 0.000 abstract 3
- 229940099472 immunoglobulin a Drugs 0.000 abstract 3
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 201000008937 atopic dermatitis Diseases 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000000968 intestinal effect Effects 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Έχει επιβεβαιωθεί σε δοκιμασίες στον άνθρωπο ότι η 1-κεστόζη έχει αποτέλεσμα αύξησης της παραγωγής ενός αντισώματος ανοσοσφαιρίνης A (IgA), αποτέλεσμα αναστολής της παραγωγής αντισώματος ανοσοσφαιρίνης Ε (IgΕ), αποτέλεσμα ενεργοποίησης της ανάπτυξης ενός εντερικού Μπιφιδοβακτηριδίου (εντερικό Μπιφιδοβακτηρίδιο) και αποτέλεσμα βελτίωσης ατοπικής δερματίτιδας σε νήπια και νεαρά παιδιά. Επί τη βάσει αυτού του ευρήματος, παρέχεται μια κατασταλτική της αλλεργίας σύνθεση, μια κατασταλτική της αλλεργίας τροφή και κατασταλτικός της αλλεργίας παράγων που περιλαμβάνει 1-κεστόζη. Εφόσον η 1-κεστόζη έχει το αποτέλεσμα αύξησης της παραγωγής ενός αντισώματος IgA, το αποτέλεσμα της αναστολής ενός αντισώματος IgΕ και το αποτέλεσμα ενεργοποίησης της ανάπτυξης ενός εντερικού Μπιφιδοβακτηριδίου, η σύνθεση, τροφή και παράγων περιλαμβάνουν 1-κεστόζη ως το δραστικό συστατικό και είναι αποτελεσματικά για την αποτροπή της ανάπτυξης και αποτελεσματικά για τη θεραπεία μιας κατάστασης αλλεργικών ασθενειών, που συμπεριλαμβάνουν ατοπική δερματίτιδα σε νήπια και νεαρά παιδιά.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005123723 | 2005-04-21 | ||
| JP2005371005A JP4162147B2 (ja) | 2005-04-21 | 2005-12-22 | アレルギー抑制剤 |
| EP06732082A EP1878738B1 (en) | 2005-04-21 | 2006-04-19 | 1-kestose for treating allergy and atopic dermatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1112180T1 true CY1112180T1 (el) | 2015-12-09 |
Family
ID=37214755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100834T CY1112180T1 (el) | 2005-04-21 | 2011-08-30 | 1-κεστοζη για θεραπεια αλλεργιας και ατοπικης δερματιτιδας |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1878738B1 (el) |
| JP (1) | JP4162147B2 (el) |
| AT (1) | ATE517907T1 (el) |
| CY (1) | CY1112180T1 (el) |
| DK (1) | DK1878738T3 (el) |
| PT (1) | PT1878738E (el) |
| SI (1) | SI1878738T1 (el) |
| WO (1) | WO2006115136A1 (el) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080059581A (ko) * | 2005-10-13 | 2008-06-30 | 메이지 세이카 가부시키가이샤 | 장내 플로라 개선용 조성물 |
| JPWO2009091035A1 (ja) * | 2008-01-18 | 2011-05-26 | 明治製菓株式会社 | １−ケストース含有焼き菓子およびその製造方法 |
| KR101833249B1 (ko) | 2010-02-22 | 2018-02-28 | 붓산 푸드사이언스 가부시키가이샤 | 상피세포간 접착 증강제 및 이것을 이용한 알러지 질환의 개선, 치료 또는 예방제 |
| WO2011108275A1 (ja) | 2010-03-04 | 2011-09-09 | 株式会社ロッテ | イムノグロブリンａ分泌促進剤 |
| JP2012176907A (ja) * | 2011-02-25 | 2012-09-13 | Glico Dairy Products Co Ltd | フラクトオリゴ糖を有効成分とするミオシン軽鎖脱リン酸化促進剤、疾患の予防又は治療剤、及び飲食品 |
| JP5923410B2 (ja) * | 2012-08-10 | 2016-05-24 | 花王株式会社 | コラーゲンゲル収縮促進剤 |
| US9963691B2 (en) | 2013-12-27 | 2018-05-08 | B Food Science Co., Ltd. | β-fructofuranosidase |
| AU2016228331A1 (en) | 2015-03-11 | 2017-09-28 | B Food Science Co., Ltd. | Improved beta-fructofuranosidase |
| WO2017159647A1 (ja) * | 2016-03-14 | 2017-09-21 | 物産フードサイエンス株式会社 | フィーカリバクテリウム属細菌増殖剤 |
| JP6275931B1 (ja) * | 2016-03-14 | 2018-02-07 | 物産フードサイエンス株式会社 | 腸内酪酸増加剤および酪酸産生菌増殖剤 |
| GB2548848A (en) * | 2016-03-30 | 2017-10-04 | The Inst Of Food Res | Levan polysaccharide to modulate cell function |
| JP7097259B2 (ja) * | 2018-08-08 | 2022-07-07 | 物産フードサイエンス株式会社 | ハナバチ寿命延長剤 |
| JP6842072B2 (ja) * | 2019-03-07 | 2021-03-17 | 物産フードサイエンス株式会社 | エガセラ属細菌の菌数抑制剤 |
| JP7372112B2 (ja) * | 2019-10-29 | 2023-10-31 | 大塚製薬株式会社 | 抗ｉ型アレルギー剤 |
| JP2021115000A (ja) | 2020-01-27 | 2021-08-10 | 物産フードサイエンス株式会社 | １−ケストースを含有する固体糖の製造方法および固体糖 |
| KR20220097322A (ko) * | 2020-12-31 | 2022-07-07 | 주식회사 삼양사 | 케스토스를 이용한 프로피온산 증진 용도 |
| CN113461751A (zh) * | 2021-07-15 | 2021-10-01 | 量子高科(广东)生物有限公司 | 一种高蔗果三糖含量低聚果糖及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02235823A (ja) * | 1989-03-09 | 1990-09-18 | Watanabe Mitsuko | 抗アレルギー剤 |
| JPH0670075B2 (ja) * | 1990-08-28 | 1994-09-07 | ホクレン農業協同組合連合会 | １―ケストース結晶およびその製造方法 |
| US5843922A (en) * | 1994-07-29 | 1998-12-01 | Fuisz Technologies Ltd. | Preparation of oligosaccharides and products therefrom |
| JPH08157379A (ja) | 1994-12-02 | 1996-06-18 | Meiji Seika Kaisha Ltd | アレルギー予防材 |
| JP3257929B2 (ja) * | 1995-06-23 | 2002-02-18 | 明治製菓株式会社 | 機能性低カロリー甘味料 |
| US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
| JPH0975035A (ja) * | 1995-09-12 | 1997-03-25 | Meiji Seika Kaisha Ltd | 機能性錠菓及び粉末飲料 |
| JP3655965B2 (ja) * | 1996-06-13 | 2005-06-02 | 明治製菓株式会社 | 結晶ケストース含有キャンデー |
| JP2000232878A (ja) * | 1999-02-12 | 2000-08-29 | Hokuren Federation Of Agricult Coop:The | フラクトシル転移酵素、並びに該酵素を用いた１−ケストース及びニストースの分別製造方法 |
| WO2003013559A1 (fr) * | 2001-08-10 | 2003-02-20 | Hokkaido Technology Licensing Office Co., Ltd. | Absorbant/adsorbant d'acide biliaire |
| JP2003201239A (ja) * | 2001-11-05 | 2003-07-18 | Meiji Milk Prod Co Ltd | 免疫賦活食品組成物 |
| JP4669235B2 (ja) * | 2004-04-21 | 2011-04-13 | ホクレン農業協同組合連合会 | 腸内環境下ビフィズス菌増殖剤 |
| JP4704007B2 (ja) * | 2004-05-12 | 2011-06-15 | ホクレン農業協同組合連合会 | 皮膚水分向上剤 |
-
2005
- 2005-12-22 JP JP2005371005A patent/JP4162147B2/ja active Active
-
2006
- 2006-04-19 SI SI200631077T patent/SI1878738T1/sl unknown
- 2006-04-19 AT AT06732082T patent/ATE517907T1/de active
- 2006-04-19 WO PCT/JP2006/308175 patent/WO2006115136A1/ja active Application Filing
- 2006-04-19 EP EP06732082A patent/EP1878738B1/en not_active Not-in-force
- 2006-04-19 DK DK06732082.0T patent/DK1878738T3/da active
- 2006-04-19 PT PT06732082T patent/PT1878738E/pt unknown
-
2011
- 2011-08-30 CY CY20111100834T patent/CY1112180T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1878738E (pt) | 2011-09-02 |
| JP4162147B2 (ja) | 2008-10-08 |
| EP1878738B1 (en) | 2011-07-27 |
| DK1878738T3 (da) | 2011-08-29 |
| EP1878738A1 (en) | 2008-01-16 |
| SI1878738T1 (sl) | 2011-12-30 |
| WO2006115136A1 (ja) | 2006-11-02 |
| JP2006321786A (ja) | 2006-11-30 |
| ATE517907T1 (de) | 2011-08-15 |
| EP1878738A4 (en) | 2008-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112180T1 (el) | 1-κεστοζη για θεραπεια αλλεργιας και ατοπικης δερματιτιδας | |
| NO20072906L (no) | Metode for forhindring eller behandling av respiratoriske infeksjoner og akutt otitis media hos barn | |
| PH12014501749A1 (en) | A nutritional composition comprising probiotics and improving sleep patterns | |
| DK1887888T3 (da) | Anvendelse af polydextrose til simulering af de funktionelle egenskaber af humane mælkeoligosaccharider hos spædbørn med kunstig næring | |
| ATE544457T1 (de) | Verfahren zur behandlung bzw. prävention systemischer entzündungen | |
| DE60026584D1 (de) | Microbielles wirkstoffabgabesystem | |
| NO20030316L (no) | Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker | |
| PH12019550208A1 (en) | Hmos blends for use in infants or young children for health purposes | |
| DE502005008790D1 (de) | Substituierte phenylaminopyrimidine | |
| ATE516809T1 (de) | Pflanzen der gattung ampelopsis und deren extrakte zur behandlung von schlafstörungen | |
| MX2019011445A (es) | Composicion que comprende oligosacaridos de la leche humana (hmo) para usar en la mejora de la memoria a corto plazo y otros beneficios cognitivos. | |
| DE60108325D1 (de) | Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung | |
| PH12018501262A1 (en) | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies | |
| NO20082986L (no) | Nye, acylisk substituerte furopyrimidinderivater og anvendelse derav for behandling av kardiovaskulaere lidelser | |
| WO2008042101A3 (en) | Probiotics for use in reducing the incidence and duration of illness | |
| TN2015000487A1 (fr) | COMPOSITION ANTl-REGURGITATION PRESERVANT LE TRANSIT INTESTINAL | |
| WO2004082548A3 (en) | Active wheelchair | |
| BRPI0503827A (pt) | métodos para prevenir ou tratar infecções respiratórias em lactentes | |
| Trivedi et al. | Patch testing in vulvar allergic contact dermatitis | |
| CY1109668T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει βακιλλο bacillus coagulans και σιμεθικονη για τη θεραπεια γαστρεντερικων παθολογιων | |
| American Academy of Family Physicians | Information from Your Family Doctor: Febrile Seizures: What You Should Know | |
| Burrascano Jr | Integrative Solutions | |
| TH15470B (th) | ผลิตภัณฑ์อาหารเพื่อป้องกันโรคภูมิแพ้อาหารชนิดรับประทาน | |
| Mykolaichuk | DEVELOPMENT OF STRESS RESISTENCE IN CHILDREN AS MEANS OF TRAUMA PREVENTION IN CASES OF EMOTIONAL AND INFORMATIONAL VIOLENCE | |
| EP1498145A4 (en) | LURE FOR THE TREATMENT AND / OR PREVENTION OF ALLERGIC DISEASE ASSOCIATED WITH CYTOKINE TH2, MUTANT PROTEIN GATA3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |